Short bowel syndrome
Clinical trials for Short bowel syndrome explained in plain language.
Never miss a new study
Get alerted when new Short bowel syndrome trials appear
Sign up with your email to follow new studies for Short bowel syndrome, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug could cut IV nutrition needs for short bowel patients
Disease control OngoingThis phase 3 trial tests a drug called teduglutide in 13 Chinese adults with short bowel syndrome who rely on IV nutrition. Participants get a daily injection for 24 weeks to see if it reduces their need for IV support. The study also checks safety and how the body processes the …
Matched conditions: SHORT BOWEL SYNDROME
Phase 3 • Sponsor: Takeda • Aim: Disease control
Last updated Sep 10, 2026 00:00 UTC
-
New device could help kids with short bowel syndrome rely less on IV nutrition
Disease control By invitation onlyThis study looks at a device called RELiZORB that attaches to a feeding tube to pre-digest fat, making it easier for children with short bowel syndrome to absorb nutrients. The goal is to see if using it daily for 90 days can safely reduce or eliminate the need for intravenous (I…
Matched conditions: SHORT BOWEL SYNDROME
Sponsor: Boston Children's Hospital • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
Could a Plant-Based drug cut IV nutrition needs for short bowel patients?
Symptom relief OngoingThis early-phase pilot study is testing a drug called crofelemer in 6 adults with short bowel syndrome who have an ileostomy and need IV nutrition. The goal is to see if crofelemer can reduce ostomy output and the amount of IV support needed over 12 weeks. Participants take the d…
Matched conditions: SHORT BOWEL SYNDROME
Early phase 1 • Sponsor: Jessica Sosio • Aim: Symptom relief
Last updated Aug 21, 2026 00:00 UTC
-
New program aims to ease burden on families of kids with rare diseases
Symptom relief By invitation onlyThis study tests a program called FACE-Rare, designed to support family caregivers of children with rare, life-limiting diseases. The program includes three sessions to help families prepare for future medical decisions and improve their quality of life. Researchers will compare …
Matched conditions: SHORT BOWEL SYNDROME
Sponsor: Children's National Research Institute • Aim: Symptom relief
Last updated Jun 27, 2026 09:00 UTC
-
Global registry tracks Real-World safety of gut drug
Knowledge-focused OngoingThis registry follows about 1,800 people with short bowel syndrome (SBS) to see how safe and effective the drug teduglutide is over the long term in everyday medical practice. It includes both patients who take teduglutide and those who do not. The main goal is to monitor for col…
Matched conditions: SHORT BOWEL SYNDROME
Sponsor: Shire • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:54 UTC